These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 17193269)

  • 21. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Fonsart J; Menet MC; Declèves X; Galons H; Crété D; Debray M; Scherrmann JM; Noble F
    Toxicol Appl Pharmacol; 2008 Jul; 230(1):117-25. PubMed ID: 18358511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats.
    Camarasa J; Marimón JM; Rodrigo T; Escubedo E; Pubill D
    Eur J Pharmacol; 2008 Jul; 589(1-3):132-9. PubMed ID: 18582864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of amphetamine, methamphetamine, MDA and MDMA in human hair by GC-EI-MS after derivatization with perfluorooctanoyl chloride.
    Johansen SS; Jornil J
    Scand J Clin Lab Invest; 2009; 69(1):113-20. PubMed ID: 18942018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
    Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrochemical and spectroscopic characterisation of amphetamine-like drugs: application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors.
    Milhazes N; Martins P; Uriarte E; Garrido J; Calheiros R; Marques MP; Borges F
    Anal Chim Acta; 2007 Jul; 596(2):231-41. PubMed ID: 17631101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive determination of MDMA and its metabolite MDA in rat blood and brain microdialysates by HPLC with fluorescence detection.
    Tomita M; Nakashima MN; Wada M; Nakashima K
    Biomed Chromatogr; 2007 Oct; 21(10):1016-22. PubMed ID: 17474141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
    Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases.
    Verschraagen M; Maes A; Ruiter B; Bosman IJ; Smink BE; Lusthof KJ
    Forensic Sci Int; 2007 Aug; 170(2-3):163-70. PubMed ID: 17658708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
    Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
    J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.
    Capela JP; Fernandes E; Remião F; Bastos ML; Meisel A; Carvalho F
    Neurotoxicology; 2007 Jul; 28(4):868-75. PubMed ID: 17572501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats.
    Kuwayama K; Inoue H; Kanamori T; Tsujikawa K; Miyaguchi H; Iwata Y; Miyauchi S; Kamo N; Kishi T
    Forensic Sci Int; 2007 Aug; 170(2-3):183-8. PubMed ID: 17614227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of PCPA and MDMA (ecstasy) on physiology, development and behavior in Drosophila melanogaster.
    Dasari S; Viele K; Turner AC; Cooper RL
    Eur J Neurosci; 2007 Jul; 26(2):424-38. PubMed ID: 17650115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thin layer chromatography/fluorescence detection of 3,4-methylenedioxy-methamphetamine and related compounds.
    Kato N; Fujita S; Ohta H; Fukuba M; Toriba A; Hayakawa K
    J Forensic Sci; 2008 Nov; 53(6):1367-71. PubMed ID: 18798772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.
    Touriño C; Ledent C; Maldonado R; Valverde O
    Biol Psychiatry; 2008 Jun; 63(11):1030-8. PubMed ID: 17950256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress in rat kidneys due to 3,4-methylenedioxymetamphetamine (ecstasy) toxicity.
    Ninković M; Selaković V; Dukić M; Milosavljević P; Vasiljević I; Jovanović M; Malicević Z
    Nephrology (Carlton); 2008 Feb; 13(1):33-7. PubMed ID: 18199099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry.
    Kim JY; Cheong JC; Kim MK; Lee JI; In MK
    Arch Pharm Res; 2008 Jun; 31(6):805-13. PubMed ID: 18563365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrolytic partial fluorination of organic compounds. 79. Anodic fluorination of spiropyrazoline-5,3'-chroman-4-ones and thiochromanone analogues. A route to aroyl fluoride derivatives.
    Dawood KM; Fuchigami T
    J Org Chem; 2005 Sep; 70(19):7537-41. PubMed ID: 16149781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ; McGregor IS; Hunt GE; Cornish JL
    Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").
    Federici M; Sebastianelli L; Natoli S; Bernardi G; Mercuri NB
    Biol Psychiatry; 2007 Sep; 62(6):680-6. PubMed ID: 17511969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.